At IRLAB Therapeutics AB’s Annual General Meeting on April 25, 2019, it was decided to divide the company’s share in a so-called share split. The resolved terms for the share split are a 5:1 split, where each current share (1) is divided into five (5) shares of the same kind. The date for implementation of the share split has now been decided.
The last day of trading in the share before the split is Monday, May 27, 2019 and the first day of trading in the share after the split is Tuesday, May 28, 2019. This means that the share price will reflect the effect of the split from May 28, 2019.
Source: IRLAB announces share split